ALCAM and colorectal cancer: Furthermore, ALCAM, in line with E-cadherin but in contrast to beta-catenin and CD44, appears to be an EMT epithelial phenotypic molecule in response to TWIST induced EMT (epithelial-mesenchymal transition) in colorectal cancer cells, and the response seems to be dependent on the microsatellite instability of the cells [24].